Assessing the safety of beta-blocker therapy in cirrhosis patients with ascites: A meta-analysis.

Robert J WongAnn RobinsonDina GinzbergChantal GomesBenny LiuTaft Bhuket

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

No significant increase in all-cause mortality was observed in cirrhosis patients with ascites treated with beta-blockers. However, given the low certainty of the evidence, high quality prospective studies are needed.

Keyphrases

angiotensin converting enzyme
cell free
angiotensin ii
case control
stem cells
mesenchymal stem cells
cell therapy
smoking cessation